Skip to main content
Caplight Logo









PharmCADD Co., Ltd.

PharmCADD Co., Ltd.

Private
BusanHealthcare & Life Scienceshttps://pharmcadd.com

Last Round

Series B

Mar 31, 2021

Total Funding Raised

$22.48M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PharmCADD Co., Ltd. is a biotechnology company that develops an AI and physics-based in-silico drug discovery platform to accelerate the development of new drug candidates.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Quantum Computing

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

drug discoveryin-silico drug discoveryAI drug discoveryAI biotechmolecular dynamicsquantum computingdrug development platformlead optimizationprotein-ligand interactionmRNA vaccine developmenttoxicity predictionSaaS drug discoverycomputational biologypharma techHPChigh-performance computing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharmCADD Co., Ltd. Comparables

Compare PharmCADD Co., Ltd. with similar companies based on industry and business-model similarity.

PharmCADD Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PolarisQB
87%
Qubit Pharmaceuticals
86%
Aigen Sciences
86%

PharmCADD Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 31, 2021
Series AJul 6, 2020
SeedMar 5, 2019

PharmCADD Co., Ltd. Investors

Notable investors and investment history

PharmCADD Co., Ltd. investors
InvestorRounds
KDB Capital CorpSeries B
DSC InvestmentSeries B
DAYLI PartnersSeries A, Series B
KB SecuritiesSeries B
Dt& InvestmentSeed
Daol InvestmentSeries A, Series B, Seed
Maple Investment PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 159% MoM, reaching 2.3K.

  • Mar 31, 2021

    $16M round with participation from KB Securities and KDB Capital Corp.

PharmCADD Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PharmCADD Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharmCADD Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBusan
Employee Range16
Year Founded2019
Last FundingMar 31, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?